Literature DB >> 11497279

Potentiation of the antiproliferative effect in vitro of doxorubicin, cisplatin and genistein by new analogues of vitamin D.

A Siwińska1, A Opolski, A Chrobak, J Wietrzyk, E Wojdat, A Kutner, W Szelejewski, C Radzikowski.   

Abstract

Numerous vitamin D3 analogues have been synthesised in recent years in order to obtain compounds with a favourable biological and therapeutic (antipsoriatic and/or antitumour) activity. Our results showed that pre-treatment for 72 hours of HL-60 human promyelocytic leukaemia cells with calcitriol or its new analogues significantly potentiated their sensitivity to the antiproliferative effect in vitro of cisplatin, doxorubicin or genistein. Moreover, for all cytotoxic agents tested a synergistic antiproliferative effect was observed. This effect was expressed as a significant decrease of the ID50 (inhibitory dose 50%) values for each cytotoxic agent applied after pretreatment with calcitriol or its analogues of HL-60 cells in comparison with the effect of cytotoxic agent applied alone. The observed in vitro potentiated antiproliferative effect of cytotoxic drugs used in combination with vitamin D or its analogues may raise the question as to whether such an effect could be expected in the in vivo situation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11497279

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  9 in total

1.  Differential interference of vitamin D analogs PRI-1906, PRI-2191, and PRI-2205 with the renewal of human colon cancer cells refractory to treatment with 5-fluorouracil.

Authors:  Agnieszka Kotlarz; Małgorzata Przybyszewska; Paweł Swoboda; Joanna Miłoszewska; Monika Anna Grygorowicz; Andrzej Kutner; Sergiusz Markowicz
Journal:  Tumour Biol       Date:  2015-10-28

Review 2.  Cisplatin in cancer therapy: molecular mechanisms of action.

Authors:  Shaloam Dasari; Paul Bernard Tchounwou
Journal:  Eur J Pharmacol       Date:  2014-07-21       Impact factor: 4.432

3.  Vitamin D analogs combined with 5-fluorouracil in human HT-29 colon cancer treatment.

Authors:  Magdalena Milczarek; Beata Filip-Psurska; Wiesław Swiętnicki; Andrzej Kutner; Joanna Wietrzyk
Journal:  Oncol Rep       Date:  2014-06-11       Impact factor: 3.906

4.  5-Lipoxygenase inhibitors potentiate 1alpha,25-dihydroxyvitamin D3-induced monocytic differentiation by activating p38 MAPK pathway.

Authors:  Lenka Stixová; Jirina Procházková; Karel Soucek; Jirina Hofmanová; Alois Kozubík
Journal:  Mol Cell Biochem       Date:  2009-05-05       Impact factor: 3.396

5.  p53 directly activates cystatin D/CST5 to mediate mesenchymal-epithelial transition: a possible link to tumor suppression by vitamin D3.

Authors:  Sabine Hünten; Heiko Hermeking
Journal:  Oncotarget       Date:  2015-06-30

6.  Synthesis and Biological Activity of Diastereomeric and Geometric Analogs of Calcipotriol, PRI-2202 and PRI-2205, Against Human HL-60 Leukemia and MCF-7 Breast Cancer Cells.

Authors:  Magdalena Milczarek; Michał Chodyński; Beata Filip-Psurska; Agnieszka Martowicz; Małgorzata Krupa; Krzysztof Krajewski; Andrzej Kutner; Joanna Wietrzyk
Journal:  Cancers (Basel)       Date:  2013-10-31       Impact factor: 6.639

7.  Vitamin D analogs enhance the anticancer activity of 5-fluorouracil in an in vivo mouse colon cancer model.

Authors:  Magdalena Milczarek; Mateusz Psurski; Andrzej Kutner; Joanna Wietrzyk
Journal:  BMC Cancer       Date:  2013-06-18       Impact factor: 4.430

8.  Antiproliferative Activity and in Vivo Toxicity of Double-Point Modified Analogs of 1,25-Dihydroxyergocalciferol.

Authors:  Justyna Trynda; Eliza Turlej; Magdalena Milczarek; Anita Pietraszek; Michał Chodyński; Andrzej Kutner; Joanna Wietrzyk
Journal:  Int J Mol Sci       Date:  2015-10-20       Impact factor: 5.923

9.  Progesterone-Calcitriol Combination Enhanced Cytotoxicity of Cisplatin in Ovarian and Endometrial Cancer Cells In Vitro.

Authors:  Ana Paucarmayta; Hannah Taitz; Latoya McGlorthan; Yovanni Casablanca; G Larry Maxwell; Kathleen M Darcy; Viqar Syed
Journal:  Biomedicines       Date:  2020-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.